GLP-1 (7–36 amide) and GLP-1 (7–37) were equally effective [32], and those with type 2 diabetes of long duration and treated with insulin after well-documented sulfonylurea secondary failure responded (despite a reasonable assumption that they would have a relatively greater reduction in beta cell mass and function) [31]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.